UK Judge Rules J&J Alzheimer Patent Invalid

Law360, New York (June 25, 2013, 6:47 PM EDT) -- A U.K. judge has ruled that a patent held by a Johnson & Johnson unit that is related to a potential treatment for Alzheimer's disease is invalid, siding with pharmaceutical maker Eli Lilly & Co., which challenged the patent, officials confirmed.

Judge Richard Arnold deemed the patent held by J&J's Janssen Alzheimer Immunotherapy Research & Development LLC invalid, according to a Bloomberg report published Tuesday. A copy of Judge Arnold's decision was not immediately available.

“We are disappointed by the outcome of this case, and we...
To view the full article, register now.